19 results on '"Cerovic, Milica"'
Search Results
2. Neural cortical organoids from self-assembling human iPSC as a model to investigate neurotoxicity in brain ischemia
- Author
-
De Paola, Massimiliano, Pischiutta, Francesca, Comolli, Davide, Mariani, Alessandro, Kelk, Joe, Lisi, Ilaria, Cerovic, Milica, Fumagalli, Stefano, Forloni, Gianluigi, and Zanier, Elisa R
- Published
- 2023
- Full Text
- View/download PDF
3. Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2
- Author
-
La Vitola, Pietro, Balducci, Claudia, Cerovic, Milica, Santamaria, Giulia, Brandi, Edoardo, Grandi, Federica, Caldinelli, Laura, Colombo, Laura, Morgese, Maria Grazia, Trabace, Luigia, Pollegioni, Loredano, Albani, Diego, and Forloni, Gianluigi
- Published
- 2018
- Full Text
- View/download PDF
4. Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum
- Author
-
Cerovic, Milica, d’Isa, Raffaele, Tonini, Raffaella, and Brambilla, Riccardo
- Published
- 2013
- Full Text
- View/download PDF
5. An in vitro model of drug-resistant seizures for selecting clinically effective antiseizure medications in Febrile Infection-Related Epilepsy Syndrome.
- Author
-
Cerovic, Milica, Di Nunzio, Martina, Craparotta, Ilaria, and Vezzani, Annamaria
- Subjects
EPILEPSY ,DRUGS ,SEIZURES (Medicine) ,EPILEPTIFORM discharges ,VALPROIC acid ,YOUNG adults - Abstract
Introduction: FIRES is a rare epileptic encephalopathy induced by acute unremitting seizures that occur suddenly in healthy children or young adults after a febrile illness in the preceding 2 weeks. This condition results in high mortality, neurological disability, and drug-resistant epilepsy. The development of new therapeutics is hampered by the lack of validated experimental models. Our goal was to address this unmet need by providing a simple tool for rapid throughput screening of new therapies that target pathological inflammatory mechanisms in FIRES. The model was not intended to mimic the etiopathogenesis of FIRES which is still unknown, but to reproduce salient features of its clinical presentation such as the age, the cytokine storm and the refractoriness of epileptic activity to antiseizure medications (ASMs). Methods: We refined an in vitro model of mouse hippocampal/temporal cortex acute slices where drug-resistant epileptic activity is induced by zero Mg2+/100 μM 4-aminopirydine. Clinical evidence suggests that acute unremitting seizures in FIRES are promoted by neuroinflammation triggered in the brain by the preceding infection. We mimicked this inflammatory component by exposing slices for 30 min to 10 μg/ml lipopolysaccharide (LPS). Results: LPS induced a sustained neuroinflammatory response, as shown by increased mRNA levels of IL-1β, CXCL1 (IL-8), TNF, and increased IL-1β/IL-1Ra ratio. Epileptiform activity was exacerbated by neuroinflammation, also displaying increased resistance to maximal therapeutic concentrations of midazolam (100 μM), phenytoin (50 μM), sodium valproate (800 μM), and phenobarbital (100 μM). Treatment of LPS-exposed slices with two immunomodulatory drugs, a mouse anti-IL-6 receptor antibody (100 μM) corresponding to tocilizumab in humans, or anakinra (1.3 μM) which blocks the IL-1 receptor type 1, delayed the onset of epileptiform events and strongly reduced the ASM-resistant epileptiform activity evoked by neuroinflammation. These drugs were shown to reduce ASM-refractory seizures in FIRES patients. Discussion: The neuroinflammatory component and the pharmacological responsiveness of epileptiform events provide a proof-of-concept validation of this in vitro model for the rapid selection of new treatments for acute ASM-refractory seizures in FIRES. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia
- Author
-
Fasano, Stefania, Bezard, Erwan, D'Antoni, Angela, Francardo, Veronica, Indrigo, Marzia, Qin, Li, Doveró, Sandra, Cerovic, Milica, Cenci, M. Angela, Brambilla, Riccardo, and Huganir, Richard L.
- Published
- 2010
7. A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies.
- Author
-
Altmann, Andre, Ryten, Mina, Di Nunzio, Martina, Ravizza, Teresa, Tolomeo, Daniele, Reynolds, Regina H., Somani, Alyma, Bacigaluppi, Marco, Iori, Valentina, Micotti, Edoardo, Di Sapia, Rossella, Cerovic, Milica, Palma, Eleonora, Ruffolo, Gabriele, Botía, Juan A., Absil, Julie, Alhusaini, Saud, Alvim, Marina K. M., Auvinen, Pia, and Bargallo, Nuria
- Subjects
MICROGLIA ,CEREBRAL cortical thinning ,EPILEPSY ,PREVENTIVE medicine ,TEMPORAL lobe ,MEMORY testing - Abstract
Aims: The causes of distinct patterns of reduced cortical thickness in the common human epilepsies, detectable on neuroimaging and with important clinical consequences, are unknown. We investigated the underlying mechanisms of cortical thinning using a systems‐level analysis. Methods: Imaging‐based cortical structural maps from a large‐scale epilepsy neuroimaging study were overlaid with highly spatially resolved human brain gene expression data from the Allen Human Brain Atlas. Cell‐type deconvolution, differential expression analysis and cell‐type enrichment analyses were used to identify differences in cell‐type distribution. These differences were followed up in post‐mortem brain tissue from humans with epilepsy using Iba1 immunolabelling. Furthermore, to investigate a causal effect in cortical thinning, cell‐type‐specific depletion was used in a murine model of acquired epilepsy. Results: We identified elevated fractions of microglia and endothelial cells in regions of reduced cortical thickness. Differentially expressed genes showed enrichment for microglial markers and, in particular, activated microglial states. Analysis of post‐mortem brain tissue from humans with epilepsy confirmed excess activated microglia. In the murine model, transient depletion of activated microglia during the early phase of the disease development prevented cortical thinning and neuronal cell loss in the temporal cortex. Although the development of chronic seizures was unaffected, the epileptic mice with early depletion of activated microglia did not develop deficits in a non‐spatial memory test seen in epileptic mice not depleted of microglia. Conclusions: These convergent data strongly implicate activated microglia in cortical thinning, representing a new dimension for concern and disease modification in the epilepsies, potentially distinct from seizure control. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
- Author
-
Pasetto, Laura, Grassano, Maurizio, Pozzi, Silvia, Luotti, Silvia, Sammali, Eliana, Migazzi, Alice, Basso, Manuela, Spagnolli, Giovanni, Biasini, Emiliano, Micotti, Edoardo, Cerovic, Milica, Carli, Mirjana, Forloni, Gianluigi, Marco, Giovanni De, Manera, Umberto, Moglia, Cristina, Mora, Gabriele, Traynor, Bryan J, Chiò, Adriano, and Calvo, Andrea
- Subjects
AMYOTROPHIC lateral sclerosis ,FRONTOTEMPORAL dementia ,CYCLOPHILINS ,MOLECULAR chaperones ,NUCLEAR proteins ,FRONTOTEMPORAL lobar degeneration ,RESEARCH ,ANIMAL experimentation ,RESEARCH methodology ,CELL receptors ,EVALUATION research ,COMPARATIVE studies ,DNA-binding proteins ,RESEARCH funding ,MICE - Abstract
Aggregation and cytoplasmic mislocalization of TDP-43 are pathological hallmarks of amyotrophic lateral sclerosis and frontotemporal dementia spectrum. However, the molecular mechanism by which TDP-43 aggregates form and cause neurodegeneration remains poorly understood. Cyclophilin A, also known as peptidyl-prolyl cis-trans isomerase A (PPIA), is a foldase and molecular chaperone. We previously found that PPIA interacts with TDP-43 and governs some of its functions, and its deficiency accelerates disease in a mouse model of amyotrophic lateral sclerosis. Here we characterized PPIA knock-out mice throughout their lifespan and found that they develop a neurodegenerative disease with key behavioural features of frontotemporal dementia, marked TDP-43 pathology and late-onset motor dysfunction. In the mouse brain, deficient PPIA induces mislocalization and aggregation of the GTP-binding nuclear protein Ran, a PPIA interactor and a master regulator of nucleocytoplasmic transport, also for TDP-43. Moreover, in absence of PPIA, TDP-43 autoregulation is perturbed and TDP-43 and proteins involved in synaptic function are downregulated, leading to impairment of synaptic plasticity. Finally, we found that PPIA was downregulated in several patients with amyotrophic lateral sclerosis and amyotrophic lateral sclerosis-frontotemporal dementia, and identified a PPIA loss-of-function mutation in a patient with sporadic amyotrophic lateral sclerosis . The mutant PPIA has low stability, altered structure and impaired interaction with TDP-43. These findings strongly implicate that defective PPIA function causes TDP-43 mislocalization and dysfunction and should be considered in future therapeutic approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages.
- Author
-
Di Nunzio, Martina, Di Sapia, Rossella, Sorrentino, Diletta, Kebede, Valentina, Cerovic, Milica, Gullotta, Giorgia S., Bacigaluppi, Marco, Audinat, Etienne, Marchi, Nicola, Ravizza, Teresa, and Vezzani, Annamaria
- Subjects
EPILEPSY ,DISEASE progression ,MAZE tests ,MICROGLIA ,ANTICONVULSANTS ,STATUS epilepticus ,KAINIC acid - Abstract
Objective: Microgliosis occurs in animal models of acquired epilepsy and in patients. It includes cell proliferation that is associated with seizure frequency and decreased neuronal cells in human epilepsy. The role of microglia proliferation in the development of acquired epilepsy is unknown; thus, we examined its contribution to spontaneous seizure, neurodegeneration, and cognitive deficits in different disease phases. Methods: We used a model of acquired epilepsy triggered by intra‐amygdala kainic acid in C57BL6N adult male mice. Mice were electroencephalographically (EEG) monitored (24/7) during status epilepticus and in early and chronic disease. Microglia proliferation was blocked by GW2580, a selective CSF1 receptor inhibitor, supplemented in the diet for 21 days from status epilepticus onset. Then, mice were returned to placebo diet until experiment completion. Control mice were exposed to status epilepticus and fed with placebo diet. Experimental mice were tested in the novel object recognition test (NORT) and in Barnes maze, and compared to control and sham mice. At the end of the behavioral test, mice were killed for brain histopathological analysis. Additionally, seizure baseline was monitored in chronic epileptic mice, then mice were fed for 14 days with GW2580 or placebo diet under 24/7 EEG recording. Results: GW2580 prevented microglia proliferation in mice undergoing epilepsy, whereas it did not affect microglia or basal excitatory neurotransmission in the hippocampus of naive mice. Mice with occluded microglia proliferation during early disease development underwent status epilepticus and subsequent epilepsy similar to placebo diet mice, and were similarly impaired in NORT, with improvement in Barnes maze. GW2580‐treated mice displayed neuroprotection in the hippocampus. In contrast, blockade of microglia proliferation in chronic epileptic mice resulted in spontaneous seizure reduction versus placebo mice. Significance: Microglia proliferation during early disease contributes to neurodegeneration, whereas in late chronic disease it contributes to seizures. Timely pharmacological interference with microglia proliferation may offer a potential target for improving disease outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?
- Author
-
Cerovic, Milica, Forloni, Gianluigi, and Balducci, Claudia
- Subjects
GUT microbiome ,ALZHEIMER'S disease ,INFLAMMATION ,ENTERIC nervous system ,CENTRAL nervous system - Abstract
Alzheimer's disease (AD) is a complex, multi-factorial disease affecting various brain systems. This complexity implies that successful therapies must be directed against several core neuropathological targets rather than single ones. The scientific community has made great efforts to identify the right AD targets beside the historic amyloid-β (Aβ). Neuroinflammation is re-emerging as determinant in the neuropathological process of AD. A new theory, still in its infancy, highlights the role of gut microbiota (GM) in the control of brain development, but also in the onset and progression of neurodegenerative diseases. Bidirectional communication between the central and the enteric nervous systems, called gut-brain axes, is largely influenced by GM and the immune system is a potential key mediator of this interaction. Growing evidence points to the role of GM in the maturation and activation of host microglia and peripheral immune cells. Several recent studies have found abnormalities in GM (dysbiosis) in AD populations. These observations raise the intriguing question whether and how GM dysbiosis could contribute to AD development through action on the immune system and whether, in a therapeutic prospective, the development of strategies preserving a healthy GM might become a valuable approach to prevent AD. Here, we review the evidence from animal models and humans of the role of GM in neuroinflammation and AD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control.
- Author
-
Trusel, Massimo, Cavaccini, Anna, Gritti, Marta, Greco, Barbara, Saintot, Pierre-Philippe, Nazzaro, Cristiano, Cerovic, Milica, Morella, Ilaria, Brambilla, Riccardo, and Tonini, Raffaella
- Abstract
Summary The basal ganglia play a critical role in shaping motor behavior. For this function, the activity of medium spiny neurons (MSNs) of the striatonigral and striatopallidal pathways must be integrated. It remains unclear whether the activity of the two pathways is primarily coordinated by synaptic plasticity mechanisms. Using a model of Parkinson’s disease, we determined the circuit and behavioral effects of concurrently regulating cell-type-specific forms of corticostriatal long-term synaptic depression (LTD) by inhibiting small-conductance Ca 2+ -activated K + channels (SKs) of the dorsolateral striatum. At striatopallidal synapses, SK channel inhibition rescued the disease-linked deficits in endocannabinoid (eCB)-dependent LTD. At striatonigral cells, inhibition of these channels counteracted a form of adenosine-mediated LTD by activating the ERK cascade. Interfering with eCB-, adenosine-, and ERK signaling in vivo alleviated motor abnormalities, which supports that synaptic modulation of striatal pathways affects behavior. Thus, our results establish a central role of coordinated synaptic plasticity at MSN subpopulations in motor control. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia.
- Author
-
Cerovic, Milica, Bagetta, Vincenza, Pendolino, Valentina, Ghiglieri, Veronica, Fasano, Stefania, Morella, Ilaria, Hardingham, Neil, Heuer, Andreas, Papale, Alessandro, Marchisella, Francesca, Giampà, Carmela, Calabresi, Paolo, Picconi, Barbara, and Brambilla, Riccardo
- Subjects
- *
DYSKINESIAS , *EXTRACELLULAR signal-regulated kinases , *DOPA , *G proteins , *BASAL ganglia , *PHENOTYPIC plasticity , *THERAPEUTICS - Abstract
Background Bidirectional long-term plasticity at the corticostriatal synapse has been proposed as a central cellular mechanism governing dopamine-mediated behavioral adaptations in the basal ganglia system. Balanced activity of medium spiny neurons (MSNs) in the direct and the indirect pathways is essential for normal striatal function. This balance is disrupted in Parkinson’s disease and in l -3,4-dihydroxyphenylalanine ( l -DOPA)-induced dyskinesia (LID), a common motor complication of current pharmacotherapy of Parkinson’s disease. Methods Electrophysiological recordings were performed in mouse cortico-striatal slice preparation. Synaptic plasticity, such as long-term potentiation (LTP) and depotentiation, was investigated. Specific pharmacological inhibitors or genetic manipulations were used to modulate the Ras-extracellular signal-regulated kinase (Ras-ERK) pathway, a signal transduction cascade implicated in behavioral plasticity, and synaptic activity in different subpopulations of striatal neurons was measured. Results We found that the Ras-ERK pathway, is not only essential for long-term potentiation induced with a high frequency stimulation protocol (HFS-LTP) in the dorsal striatum, but also for its reversal, synaptic depotentiation. Ablation of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1), a neuronal activator of Ras proteins, causes a specific loss of HFS-LTP in the medium spiny neurons in the direct pathway without affecting LTP in the indirect pathway. Analysis of LTP in animals with unilateral 6-hydroxydopamine lesions (6-OHDA) rendered dyskinetic with chronic L-DOPA treatment reveals a complex, Ras-GRF1 and pathway-independent, apparently stochastic involvement of ERK. Conclusions These data not only demonstrate a central role for Ras-ERK signaling in striatal LTP, depotentiation, and LTP restored after L-DOPA treatment but also disclose multifaceted synaptic adaptations occurring in response to dopaminergic denervation and pulsatile administration of L-DOPA. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.
- Author
-
Nazzaro, Cristiano, Greco, Barbara, Cerovic, Milica, Baxter, Paul, Rubino, Tiziana, Trusel, Massimo, Parolaro, Daniela, Tkatch, Tatiana, Benfenati, Fabio, Pedarzani, Paola, and Tonini, Raffaella
- Subjects
PHYSIOLOGICAL adaptation ,CANNABINOIDS ,NERVOUS system ,POTASSIUM channels ,LABORATORY mice - Abstract
Endocannabinoids (eCBs) regulate neuronal activity in the dorso-lateral striatum (DLS), a brain region that is involved in habitual behaviors. How synaptic eCB signaling contributes to habitual behaviors under physiological and pathological conditions remains unclear. Using a mouse model of cannabinoid tolerance, we found that persistent activation of the eCB pathway impaired eCB-mediated long-term depression (LTD) and synaptic depotentiation in the DLS. The loss of eCB LTD, occurring preferentially at cortical connections to striatopallidal neurons, was associated with a shift in behavioral control from goal-directed action to habitual responding. eCB LTD and behavioral alterations were rescued by in vivo modulation of small-conductance calcium activated potassium channel (SK channel) activity in the DLS, which potentiates eCB signaling. Our results reveal a direct relationship between drug tolerance and changes in control of instrumental performance by establishing a central role for eCB LTD in habit expression. In addition, SK channels emerge as molecular targets to fine tune the eCB pathway under pathological conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
14. Viral vector approaches to modify gene expression in the brain
- Author
-
Papale, Alessandro, Cerovic, Milica, and Brambilla, Riccardo
- Subjects
- *
GENETIC vectors , *GENE expression , *BRAIN physiology , *VIRAL genomes , *GENETIC transformation , *NEUROPLASTICITY , *DRUG addiction , *PHYSIOLOGICAL aspects of memory - Abstract
Abstract: The use of viral vectors as gene transfer tools for the central nervous system has seen a significant growth in the last decade. Improvements in the safety, efficiency and specificity of vectors for clinical applications have proven to be beneficial also for basic neuroscience research. This review will discuss the viral systems currently available to neuroscientists and some of the recent achievements in the study of synaptic function, memory and drug addiction. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
15. ERK-Dependent Modulation of Cerebellar Synaptic Plasticity after Chronic Δ9-Tetrahydrocannabinol Exposure.
- Author
-
Tonini, Raffaella, Ciardo, Sonia, Cerovic, Milica, Rubino, Tiziana, Parolaro, Daniela, Mazzanti, Michele, and Zippel, Renata
- Subjects
CEREBELLUM ,NEUROPLASTICITY ,CANNABINOIDS ,TETRAHYDROCANNABINOL ,DRUG tolerance ,ADENOSINES ,NEURAL transmission - Abstract
Chronic exposure to Δ9-tetrahydrocannabinol (THC) induces tolerance to cannabinoid-induced locomotor effects, which are mediated by cannabinoid receptors (CB1Rs) located in motor control regions, including the cerebellum. There is substantial evidence of cerebellar CB1R molecular adaptation and modifications in receptor signaling after prolonged cannabinoid exposure. However, very little is known about the effects of chronic cannabinoid administration on cerebellar synaptic plasticity, which may contribute to the development of cannabinoid behavioral tolerance. In the cerebellar cortex, activation of CB1R inhibits excitatory synaptic transmission at parallel fiber (PF)-Purkinje cell (PC) synapses by decreasing neurotransmitter release. Our study aimed to investigate the neurophysiological adaptive responses occurring at cerebellar PF-PC cell synapses after repeated THC exposure. In THC-tolerant mice, an increase of the basal release probability was found at PF-PC synapses, in parallel with a facilitation of slow mGluR1 (metabotropic glutamate receptor type 1)-mediated excitatory postsynaptic currents and a reduced sensitivity to the inhibitory effects of the CB1R agonist CP55,940 [(-)-cis-3-[2-hydroxy-4-(1,1- dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol]. Additionally, after repeated THC exposures, presynaptic PF-PC longterm potentiation was blocked by A1R (adenosine receptor-1) activation. Inhibition of the extracellular signal regulated kinase (ERK) pathway prevented these alterations of cerebellar synaptic transmission and plasticity. In summary, we provide evidence for ERK-dependent modulatory mechanisms at PF-PC synapses after chronic THC administration. This contributes to generation of forms of pathological synaptic plasticity that might play a role in cannabinoid dependence. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
16. The prion protein family member Shadoo induces spontaneous ionic currents in cultured cells.
- Author
-
Nyeste, Antal, Stincardini, Claudia, Bencsura, Petra, Cerovic, Milica, Biasini, Emiliano, and Welker, Ervin
- Abstract
Some mutant forms of the cellular prion protein (PrP
C ) carrying artificial deletions or point mutations associated with familial human prion diseases are capable of inducing spontaneous ionic currents across the cell membrane, conferring hypersensitivity to certain antibiotics to a wide range of cultured cells and primary cerebellar granular neurons (CGNs). These effects are abrogated when the wild type (WT) form is co-expressed, suggesting that they might be related to a physiological activity of PrPC . Interestingly, the prion protein family member Shadoo (Sho) makes cells hypersensitive to the same antibiotics as mutant PrP-s, an effect that is diminished by the co-expression of WT-PrP. Here, we report that Sho engages in another mutant PrP-like activity: it spontaneously induces large ionic currents in cultured SH-SY5Y cells, as detected by whole-cell patch clamping. These currents are also decreased by the co-expression of WT-PrP. Furthermore, deletion of the N-terminal (RXXX)8 motif of Sho, mutation of the eight arginine residues of this motif to glutamines, or replacement of the hydrophobic domain by that of PrP, also diminish Sho-induced ionic currents. Our results suggest that the channel activity that is also characteristic to some pathogenic PrP mutants may be linked to a physiological function of Sho. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
17. A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.
- Author
-
Massignan, Tania, Cimini, Sara, Stincardini, Claudia, Cerovic, Milica, Vanni, Ilaria, Elezgarai, Saioa R., Moreno, Jorge, Stravalaci, Matteo, Negro, Alessandro, Sangiovanni, Valeria, Restelli, Elena, Riccardi, Geraldina, Gobbi, Marco, Castilla, Joaquín, Borsello, Tiziana, Nonno, Romolo, and Biasini, Emiliano
- Published
- 2016
- Full Text
- View/download PDF
18. Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.
- Author
-
Iori, Valentina, Iyer, Anand M., Ravizza, Teresa, Beltrame, Luca, Paracchini, Lara, Marchini, Sergio, Cerovic, Milica, Hill, Cameron, Ferrari, Mariella, Zucchetti, Massimo, Molteni, Monica, Rossetti, Carlo, Brambilla, Riccardo, Steve White, H., D'Incalci, Maurizio, Aronica, Eleonora, and Vezzani, Annamaria
- Subjects
- *
TREATMENT effectiveness , *TREATMENT of epilepsy , *INTERLEUKIN-1 receptors , *TARGETED drug delivery , *DRUG development - Abstract
We recently discovered that forebrain activation of the IL-1 receptor/Toll-like receptor (IL-1R1/TLR4) innate immunity signal plays a pivotal role in neuronal hyperexcitability underlying seizures in rodents. Since this pathway is activated in neurons and glia in human epileptogenic foci , it represents a potential target for developing drugs interfering with the mechanisms of epileptogenesis that lead to spontaneous seizures. The lack of such drugs represents a major unmet clinical need. We tested therefore novel therapies inhibiting the IL-1R1/TLR4 signaling in an established murine model of acquired epilepsy. We used an epigenetic approach by injecting a synthetic mimic of micro(mi)RNA-146a that impairs IL1R1/TLR4 signal transduction, or we blocked receptor activation with antiinflammatory drugs. Both interventions when transiently applied to mice after epilepsy onset, prevented disease progression and dramatically reduced chronic seizure recurrence, while the anticonvulsant drug carbamazepine was ineffective. We conclude that IL-1R1/TLR4 is a novel potential therapeutic target for attaining disease-modifications in patients with diagnosed epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies.
- Author
-
Papale, Alessandro, d’Isa, Raffaele, Menna, Elisabetta, Cerovic, Milica, Solari, Nicola, Hardingham, Neil, Cambiaghi, Marco, Cursi, Marco, Barbacid, Mariano, Leocani, Letizia, Fasano, Stefania, Matteoli, Michela, and Brambilla, Riccardo
- Subjects
- *
INTELLECTUAL disabilities , *GABAERGIC neurons , *SYNAPTOGENESIS , *RAP1 proteins , *TASK performance , *EXTRACELLULAR signal-regulated kinases , *BEHAVIORAL assessment - Abstract
Background Dysregulation of Ras-extracellular signal-related kinase (ERK) signaling gives rise to RASopathies, a class of neurodevelopmental syndromes associated with intellectual disability. Recently, much attention has been directed at models bearing mild forms of RASopathies whose behavioral impairments can be attenuated by inhibiting the Ras-ERK cascade in the adult. Little is known about the brain mechanisms in severe forms of these disorders. Methods We performed an extensive characterization of a new brain-specific model of severe forms of RASopathies, the KRAS 12V mutant mouse. Results The KRAS 12V mutation results in a severe form of intellectual disability, which parallels mental deficits found in patients bearing mutations in this gene. KRAS 12V mice show a severe impairment of both short- and long-term memory in a number of behavioral tasks. At the cellular level, an upregulation of ERK signaling during early phases of postnatal development, but not in the adult state, results in a selective enhancement of synaptogenesis in gamma-aminobutyric acidergic interneurons. The enhancement of ERK activity in interneurons at this critical postnatal time leads to a permanent increase in the inhibitory tone throughout the brain, manifesting in reduced synaptic transmission and long-term plasticity in the hippocampus. In the adult, the behavioral and electrophysiological phenotypes in KRAS 12V mice can be temporarily reverted by inhibiting gamma-aminobutyric acid signaling but not by a Ras-ERK blockade. Importantly, the synaptogenesis phenotype can be rescued by a treatment at the developmental stage with Ras-ERK inhibitors. Conclusions These data demonstrate a novel mechanism underlying inhibitory synaptogenesis and provide new insights in understanding mental dysfunctions associated to RASopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.